Literature DB >> 31807517

Combination era, using combined vasopressors showed benefits in treating septic shock patients: a network meta-analysis of randomized controlled trials.

Chongxiang Chen1,2, Lanlan Pang3, Yanyan Wang3, Tianmeng Wen4, Wu Yu3, Xiaolei Yue3, Yuming Rong2, Wei Liao2.   

Abstract

BACKGROUND: Septic shock is one of the major healthcare problems, affecting millions of people around the world every year. The object of this study is to find the best kind of regimen of vasopressors treatment in septic shock.
METHODS: The PubMed, and the Web of Science were used to find the included studies. Stata 15.1 was performed to this systemic review and network meta-analysis.
RESULTS: After searching and screening the articles, finally we included articles about 31 randomized controlled trials (RCTs), 11 arms (dopamine, dopexamine, epinephrine, norepinephrine, norepinephrine + dobutamine, norepinephrine + dopexamine, norepinephrine + epinephrine, norepinephrine + vasopressin, phenylephrine, terlipressin, vasopressin) and total 5,928 patients with septic shock. Compared with dopamine, the regimens (epinephrine, norepinephrine, norepinephrine + dobutamine, and vasopressin) have significantly lower 28-day mortality. Ranking the regimens in the order of estimated probabilities of each treatment by using the network meta-analysis for 28-day mortality, the result showed that norepinephrine + dopexamine was the best one (57.3%), followed by norepinephrine + epinephrine (14.8%), norepinephrine + dobutamine (10.9%), dopexamine (11.2%), terlipressin (9.8%), norepinephrine + vasopressin (2.4%), phenylephrine (1.2%), epinephrine (1.0%), vasopressin (0.5%), norepinephrine (0.0%), and dopamine (0.0%). In addition, for the results of arrhythmia and increased heart rate, the combination regimens groups did not showed inferiority to other single regimen groups.
CONCLUSIONS: Single dopamine had significantly higher 28d mortality. Combination regimens of vasopressors accounted for the best three therapeutic regimens. In treating patients with septic shock, using combining regimens probably gets more benefits. 2019 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Septic shock; norepinephrine; vasopressor

Year:  2019        PMID: 31807517      PMCID: PMC6861808          DOI: 10.21037/atm.2019.09.134

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  61 in total

1.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

2.  A randomized trial comparing terlipressin and noradrenaline in patients with cirrhosis and septic shock.

Authors:  Ashok Choudhury; Chandan K Kedarisetty; Chitranshu Vashishtha; Deepak Saini; Sachin Kumar; Rakhi Maiwall; Manoj K Sharma; Ajeet S Bhadoria; Guresh Kumar; Yogendra K Joshi; Shiv K Sarin
Journal:  Liver Int       Date:  2016-10-20       Impact factor: 5.828

3.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Mervyn Singer; Clifford S Deutschman; Christopher Warren Seymour; Manu Shankar-Hari; Djillali Annane; Michael Bauer; Rinaldo Bellomo; Gordon R Bernard; Jean-Daniel Chiche; Craig M Coopersmith; Richard S Hotchkiss; Mitchell M Levy; John C Marshall; Greg S Martin; Steven M Opal; Gordon D Rubenfeld; Tom van der Poll; Jean-Louis Vincent; Derek C Angus
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

4.  [Effects of levosimendan on hemodynamics and cardiac function in patients with septic shock].

Authors:  Mingxing Fang; Shimin Dong
Journal:  Zhonghua Wei Zhong Bing Ji Jiu Yi Xue       Date:  2014-10

5.  Low-dose vasopressin in the treatment of vasodilatory septic shock.

Authors:  M B Malay; R C Ashton; D W Landry; R N Townsend
Journal:  J Trauma       Date:  1999-10

6.  Double-Blind Randomized Clinical Trial Comparing Dopamine and Epinephrine in Pediatric Fluid-Refractory Hypotensive Septic Shock.

Authors:  Karthik Narayanan Ramaswamy; Sunit Singhi; Muralidharan Jayashree; Arun Bansal; Karthi Nallasamy
Journal:  Pediatr Crit Care Med       Date:  2016-11       Impact factor: 3.624

7.  A comparison of epinephrine and norepinephrine in critically ill patients.

Authors:  John A Myburgh; Alisa Higgins; Alina Jovanovska; Jeffrey Lipman; Naresh Ramakrishnan; John Santamaria
Journal:  Intensive Care Med       Date:  2008-07-25       Impact factor: 17.440

8.  Effects of Levosimendan on Cellular Metabolic Alterations in Patients With Septic Shock: A Randomized Controlled Pilot Study.

Authors:  Zied Hajjej; Bilel Meddeb; Walid Sellami; Iheb Labbene; Andrea Morelli; Mustapha Ferjani
Journal:  Shock       Date:  2017-09       Impact factor: 3.454

9.  Terlipressin for septic shock patients: a meta-analysis of randomized controlled study.

Authors:  Yibing Zhu; Huibin Huang; Xiuming Xi; Bin Du
Journal:  J Intensive Care       Date:  2019-03-12

10.  Levosimendan Versus Dobutamine in Myocardial Injury Patients with Septic Shock: A Randomized Controlled Trial.

Authors:  Jianb-biao Meng; Ma-hong Hu; Zhi-zhen Lai; Chun-lian Ji; Xiu-juan Xu; Geng Zhang; Shuyuan Tian
Journal:  Med Sci Monit       Date:  2016-05-03
View more
  1 in total

1.  Of Size and Men: A Call for Larger Trials and Meta-Analyses on Vasopressors During General Anesthesia.

Authors:  Giuseppe Biondi-Zoccai; Elena Cavarretta; Giacomo Frati; Francesco Versaci
Journal:  J Cardiothorac Vasc Anesth       Date:  2020-09-15       Impact factor: 2.628

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.